Eptacog beta (activated) (Cevenfacta)
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- November 2022
Comments
Use in adults and adolescents aged ≥12 years for the treatment of
bleeding episodes and for the prevention of bleeding in those undergoing
surgery or invasive procedures. Await clinician request to JAPC for formal review.Do Not Prescribe (DNP) Drug Classifications
- 2: Have a lack of data on safety compared with standard therapy
- 3: Have known increase in risk of adverse events compared with standard therapy
- 5: Less cost-effective than current standard therapy
search again
